FLUTICASONE PROPIONATE AND SALMETEROL and OFF LABEL USE

Overview

OFF LABEL USE is the #11 most commonly reported adverse reaction for FLUTICASONE PROPIONATE AND SALMETEROL, manufactured by GlaxoSmithKline LLC. There are 1,483 FDA adverse event reports linking FLUTICASONE PROPIONATE AND SALMETEROL to OFF LABEL USE. This represents approximately 1.9% of all 78,422 adverse event reports for this drug.

Patients taking FLUTICASONE PROPIONATE AND SALMETEROL who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

OFF LABEL USE1,483 of 78,422 reports

OFF LABEL USE is a less commonly reported adverse event for FLUTICASONE PROPIONATE AND SALMETEROL, but still significant enough to appear in the safety profile.

Other Side Effects of FLUTICASONE PROPIONATE AND SALMETEROL

In addition to off label use, the following adverse reactions have been reported for FLUTICASONE PROPIONATE AND SALMETEROL:

DYSPNOEA — 6,291 reports
DRUG INEFFECTIVE — 4,817 reports
PRODUCT QUALITY ISSUE — 2,665 reports
COUGH — 2,499 reports
ASTHMA — 2,167 reports
PNEUMONIA — 2,146 reports
DRUG DOSE OMISSION — 1,998 reports
PRODUCT DOSE OMISSION ISSUE — 1,867 reports
MALAISE — 1,571 reports
WRONG TECHNIQUE IN DEVICE USAGE PROCESS — 1,498 reports

Other Drugs Associated with OFF LABEL USE

The following drugs have also been linked to off label use in FDA adverse event reports:

0XYGEN ABACAVIR SULFATE ABATACEPT ABIRATERONE ACETATE ACALABRUTINIB ACETAMINOPHEN ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN AND IBUPROFEN ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN, CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, IBUPROFEN

Does FLUTICASONE PROPIONATE AND SALMETEROL cause OFF LABEL USE?

OFF LABEL USE has been reported as an adverse event in 1,483 FDA reports for FLUTICASONE PROPIONATE AND SALMETEROL. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is OFF LABEL USE with FLUTICASONE PROPIONATE AND SALMETEROL?

OFF LABEL USE accounts for approximately 1.9% of all adverse event reports for FLUTICASONE PROPIONATE AND SALMETEROL, making it a notable side effect.

What should I do if I experience OFF LABEL USE while taking FLUTICASONE PROPIONATE AND SALMETEROL?

If you experience off label use while taking FLUTICASONE PROPIONATE AND SALMETEROL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.